Cesca Therapeutics

Cesca Therapeutics restructures, cuts 15 jobs

Thursday, September 17, 2015

Cesca Therapeutics, an autologous cell-based regenerative medicine company, has undertaken a restructuring initiative geared toward reducing costs associated with its traditional cord blood banking business and further aligning available resources behind the company’s clinical programs, including the phase III pivotal clinical trial for no option critical limb ischemia (CLI) patients, recently approved by the FDA.

[Read More]